Current trends of antibiotic resistance in clinical isolates of Staphylococcus aureus
Kapil Dev SHARMA, Rajendra Prasad SAINI, Loganathan KARTHIK
Current trends of antibiotic resistance in clinical isolates of Staphylococcus aureus
Staphyloccus aureus (S. aureus) is a well known human pathogen known to causes a verity of infections in humans. In recent years S. aureus is reported to show drug resistant toward commonly known drugs. Therefore, this study was designed to study the pattern of antibiotic resistance in 50 clinical isolates of S. aureus isolated at Dhanwantri Hospital and Research Centre, Jaipur, Rajasthan, India. S. aureus cultures were isolated from different clinical samples, pus, throat swabs and urine on Blood agar and MacConkey agar and Chrom agar plats and characterized by an array of microscopic and biochemical tests. Antibiotic sensitivity test was performed by standard disc diffusion method (Kirby bayer's method) on Muller Hinton agar plates. During this study, among 50 S. aureus isolates 48 (96%) were found to be resistance toward Aztreonam and Doxicycline followed by Ciprofloxacin (n = 45, 90%), Cefpodoxime and Ceftazidime (n = 44, 88%), Cefuroxime (n = 40, 80%), Pipracillin+ Tazobactum (n = 38, 76%), Cefoparazone (n = 36, 72%), Amoxicillin+ Clavulanic acid and Ceftriaxone (n = 33, 66%), Levofloxacin (n = 32, 64%), Moxifloxacin (n = 31, 62%), Ofloaxacin (n = 25, 50%), Cloxacillin (n = 22, 44%), Azithromycin (n = 21, 42%), Clindamycin (n = 19, 38%), Meropenem (n = 18, 36%), Clarithromycin (n = 16, 32%), Ampicillin+ sulbactam (n = 13, 26%), Amikacin (n = 12, 24%), Impipenem (n = 8, 16%), Linezolid and Methicillin (n = 7, 14%) and Teicoplanin (n = 3, 6%). In conclusion, the isolated S. aureus found to be resistant toward common antibiotics, however all isolates were found to be susceptible to Vancomycin.
Staphyloccus aureus / infections / antibiotic resistance
[1] |
Appelbaum P C (2006). MRSA—the tip of the iceberg. Clin Microbiol Infect, 12(s2 Suppl 2): 3−10
CrossRef
Pubmed
Google scholar
|
[2] |
Bal A M, Gould I M (2005). Antibiotic resistance in Staphylococcus aureus and its relevance in therapy. Expert Opin Pharmacother, 6(13): 2257−2269
CrossRef
Pubmed
Google scholar
|
[3] |
Bamberger D M, Boyd S E (2005). Management of Staphylococcus aureus infections. Am Fam Physician, 72(12): 2474−2481
Pubmed
|
[4] |
Chambers H F (2001). The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis, 7(2): 178−182
CrossRef
Pubmed
Google scholar
|
[5] |
Iqbal M, Ali K M, Daraz B, Siddique U (2004). Bacteriology of mastitic milk and in vitro antibiogram of the isolates. Pakistan Vet. J, 24: 161−164
|
[6] |
Livermore D M (2000). Antibiotic resistance in staphylococci. Int J Antimicrob Agents, 16(Suppl 1): S3−S10
CrossRef
Pubmed
Google scholar
|
[7] |
Lowy F D (2003). Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest, 111(9): 1265−1273
CrossRef
Pubmed
Google scholar
|
[8] |
Pantosti A, Sanchini A, Monaco M (2007). Mechanisms of antibiotic resistance in Staphylococcus aureus. Future Microbiol, 2(3): 323−334
CrossRef
Pubmed
Google scholar
|
[9] |
Rayner C, Munckhof W J (2005). Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus. Intern Med J, 35(s2 Suppl 2): S3−S16
CrossRef
Pubmed
Google scholar
|
[10] |
WHO (1999). Leading cause of death.
|
/
〈 | 〉 |